Dmitry Kaminskiy is an innovative entrepreneur and investor who is active in the fields of BioTech, FinTech, BlockChain, Artificial Intelligence and the intersection of these industries and technologies through their convergence. Kaminskiy is a co-founder and a managing partner at Deep Knowledge Ventures, a Hong Kong based investment fund focused on DeepTech and advanced science projects utilizing impact investment approach.
Considering the significant growth of interest to the Longevity industry, Deep Knowledge Life Sciences, a London-based subsidiary investment fund, has increased its activity in 2017 and will actively expand its portfolio to catch the wave edge of the rising trend “Investing in Longevity”.
Insilico Medicine is the flagship among portfolio companies, a leading pioneer at the intersection of Artificial Intelligence, personalized medicine and Longevity.
Dmitry is a frequent speaker on the topics of AI and Longevity. During the last year he spoke at conferences organized in London by The Economist “Aging Societies and The Business of Longevity”, Financial Times “Smart Machines vs Smart People”, at the Future Finance Forum in Seoul “AI in Finance”, as well as several others at Oxford and Cambridge Universities.
In addition to his business experience, Kaminskiy is involved in several scientific endeavours. He strongly believes in the fact that humans should live longer, healthier lives. Besides AI, Dmitry’s major interest is anti-aging and healthy longevity which he has engaged in through business, research and public activities. Dmitry is well known for his support of life extension think-tanks in Oxford and Cambridge and many other non-profit activities. He is the Managing Trustee of the Biogerontology Research Foundation UK, a charity expediting the coming paradigm shift from disease treatment to personalized precision prevention. Dmitry’s $1 million USD prize for the first person to reach their 123th birthday went viral, and was widely covered by the world’s top media.
Dmitry adheres to the principal of “Impact Investment” in all his business activities, believing that business should act to have significant impact for social good. He operates according to the maxim that business should not be separated from societal good and humanitarianism, and his activities in both business and the non-profit sector are aimed at the shared goal of advancing exponential and disruptive technologies to accelerate positive paradigm shifts in finance, healthcare and AI.
Dmitry Kaminskiy and Deep Knowledge Ventures are actively involved in the rising Crypto Economy working on several Blockchain projects in the field of LegalTech and RegTech with the aim to create sophisticated platforms and frameworks to apply novel financial tools and strategies to optimise distribution of venture funding to provide DeepTech projects with sufficient investment budgets.
But the most priority project for Dmitry in his life is building Global Longevity Consortium as the decentralized knowledge platform and next generation Non-Profit foundation which will serve as the collective mind of the Longevity sphere and will be the key driver for the Longevity Index Hedge Fund, a project on the intersection and convergence of Cryptoeconomy, Novel Financial Strategies, Precision Medicine and Longevity.
Kaminskiy is confident that this will create the largest paradigm shift in the industry since its emergence, and sees it as a project poised to democratize, optimize and radically disrupt the Longevity Industry for the betterment of humanity.
Mr. Dmitry Kaminskiy serves as the Managing Director and Senior Partner of Deep Knowledge Ventures. Mr. Kaminskiy has deep Knowledge Ventures. He co-founded and helped finance the Center for Biogerontology and Regenerative Medicine at the Moscow Institute of Physics and Technology. Mr. Kaminskiy serves as a Member of the Board of Trustees of The Biogerontology Research Foundation.
National Research University of Electronic Technology / MIET